Rachel Roubein is a reporter at The Washington Post, specializing in health reporting with a particular focus on the Food and Drug Administration. Her work encompasses a range of themes including healthcare administration, public health, and consumer health, as well as topics related to drugs and medication. Rachel's insights and analyses have been featured in prominent publications such as POLITICO, The Boston Globe, and Yahoo News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rachel Roubein, Lena H. Sun, Brady Dennis
U.S. officials are prepared to allow some of the 18 American passengers exposed to a unique strain of hantavirus to leave a special quarantine facility in Nebraska as early as Monday. But they are still negotiating with state officials over how closely the passengers should be monitored for the remainder of the 42-day quarantine after returning home, according to three people familiar with the response.
By: Rachel Roubein, Clara Ence Morse, Lauren Weber
Zach Lahn, a first-time candidate, pulled off an upset win against Trump-endorsed Rep. Randy Feenstra in Iowa after challenging Big Ag on pesticides.
By: Rachel Roubein
The FDA has approved a new sunscreen additive for the first time in two decades. Consumer groups have been pushing the change for years.
By: Rachel Roubein, Lena H. Sun
The public effort to revamp U.S. vaccine policy has quieted. Behind the scenes is a different story.
By: Lena H. Sun, Rachel Roubein
In February at Republicans' private Capitol Hill clubhouse, President Donald Trump's chief pollster delivered a message about voters and their desire to hear about affordability.
By: Rachel Roubein, Lauren Weber
The chains of amino acids are increasingly marketed for antiaging and health benefits. However, medical experts say many of those claims have not yet been fully tested.
This week, FDA career staff scientists said there isn’t enough evidence to allow certain peptides to be produced by compounding pharmacies.
By: Lauren Weber, Rachel Roubein
By and Food and Drug Administration career scientists said there isn't enough evidence to allow certain peptides to be produced by
By: Rachel Roubein
Deaths from flu and pneumonia, meanwhile, rose to be the eighth-leading cause of death last year amid lower uptake of the flu shot.
By: Rachel Roubein
The U.S. death rate fell to the lowest point on record last year, while flu and pneumonia rose to be one of the top 10 leading causes of death, according
